Sorrento Therapeutics Inc
Change company Symbol lookup
Select an option...
SRNE Sorrento Therapeutics Inc
TC TuanChe Ltd
ENSG Ensign Group Inc
INO Inovio Pharmaceuticals Inc
WHR Whirlpool Corp
TTOO T2 Biosystems Inc
AAPL Apple Inc
HOKCY Hong Kong and China Gas Co Ltd
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T), antibody-drug conjugates (ADC), as well as bispecific antibody approaches. Additionally, Sorrento Therapeutics segment also includes Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. The Scilex segment is organized around its non-opioid pain management operations.

Closing Price
$9.43
Day's Change
-0.05 (-0.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.46
Day's Low
8.64
Volume
(Average)
Volume:
35,168,066

10-day average volume:
34,365,421
35,168,066

CLASS ACTION UPDATE for SRNE, CLNY and ERII: Levi and Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

6:21 am ET July 27, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / July 27, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SRNE Shareholders Click Here: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=8183&wire=1CLNY Shareholders Click Here: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=8183&wire=1ERII Shareholders Click Here: https://www.zlk.com/pslra-1/energy-recovery-inc-loss-submission-form?prid=8183&wire=1

* ADDITIONAL INFORMATION BELOW *

Sorrento Therapeutics, Inc. (NASDAQ: SRNE)

SRNE Lawsuit on behalf of: investors who purchased May 15, 2020 - May 22, 2020Lead Plaintiff Deadline : July 27, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=8183&wire=1

According to the filed complaint, during the class period, Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Colony Capital, Inc. (NYSE: CLNY)

CLNY Lawsuit on behalf of: investors who purchased August 9, 2019 - May 7, 2020Lead Plaintiff Deadline : July 27, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=8183&wire=1

According to the filed complaint, during the class period, Colony Capital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Colony's sale of its industrial real estate portfolio and the bifurcation of Colony Credit Real Estate's portfolio were foreseeably likely to negatively impact Colony's financial and operating results; (ii) certain of Colony's remaining portfolio companies carried unsustainable levels of debt secured by hotels and healthcare-related properties and were thus at a significant risk of default; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Energy Recovery, Inc. (NASDAQ: ERII)

ERII Lawsuit on behalf of: investors who purchased August 2, 2017 - June 29, 2020Lead Plaintiff Deadline : September 21, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/energy-recovery-inc-loss-submission-form?prid=8183&wire=1

According to the filed complaint, during the class period, Energy Recovery, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had different strategic perspectives regarding commercialization of the Company's VorTeq technology than Schlumberger Technology Corp., which had exclusive rights to the use of VorTeq (ii) these differences created substantial risk of early termination of the Company's exclusive licensing agreement with Schlumberger; (iii) accordingly, the revenue guidance and expectations of future license revenue was false and lacked reasonable basis; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com: https://www.accesswire.com/599002/CLASS-ACTION-UPDATE-for-SRNE-CLNY-and-ERII-Levi-and-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.